Your browser doesn't support javascript.
loading
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
Janes, Holly E; Cohen, Kristen W; Frahm, Nicole; De Rosa, Stephen C; Sanchez, Brittany; Hural, John; Magaret, Craig A; Karuna, Shelly; Bentley, Carter; Gottardo, Raphael; Finak, Greg; Grove, Douglas; Shen, Mingchao; Graham, Barney S; Koup, Richard A; Mulligan, Mark J; Koblin, Beryl; Buchbinder, Susan P; Keefer, Michael C; Adams, Elizabeth; Anude, Chuka; Corey, Lawrence; Sobieszczyk, Magdalena; Hammer, Scott M; Gilbert, Peter B; McElrath, M Juliana.
Afiliación
  • Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Frahm N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Sanchez B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Bentley C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Finak G; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Grove D; The Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Shen M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
  • Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
  • Mulligan MJ; Emory Vaccine Center, Emory University, Atlanta, Georgia.
  • Koblin B; Laboratory of Infectious Disease Prevention, New York Blood Center, New York.
  • Buchbinder SP; Departments of Medicine and Epidemiology/Biostatistics, University of California San Francisco.
  • Keefer MC; University of Rochester Medical Center, School of Medicine and Dentistry, New York.
  • Adams E; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, and.
  • Anude C; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland; and.
  • Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • Sobieszczyk M; Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York.
  • Hammer SM; Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York.
  • Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
  • McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, and.
J Infect Dis ; 215(9): 1376-1385, 2017 05 01.
Article en En | MEDLINE | ID: mdl-28199679
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Infecciones por VIH / Vacunas contra el SIDA / Linfocitos T CD8-positivos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Infect Dis Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Infecciones por VIH / Vacunas contra el SIDA / Linfocitos T CD8-positivos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Infect Dis Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos